For: | Tovo CV, Fernandes SA, Buss C, de Mattos AA. Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review. World J Hepatol 2017; 9(6): 326-332 [PMID: 28293382 DOI: 10.4254/wjh.v9.i6.326] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i6/326.htm |
Number | Citing Articles |
1 |
Vittoria Zambon Azevedo, Cristina Alina Silaghi, Thomas Maurel, Horatiu Silaghi, Vlad Ratziu, Raluca Pais. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Frontiers in Nutrition 2022; 8 doi: 10.3389/fnut.2021.774030
|
2 |
Maurizio Marra, Rosa Sammarco, Antonino De Lorenzo, Ferdinando Iellamo, Mario Siervo, Angelo Pietrobelli, Lorenzo Maria Donini, Lidia Santarpia, Mauro Cataldi, Fabrizio Pasanisi, Franco Contaldo. Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview. Contrast Media & Molecular Imaging 2019; 2019: 1 doi: 10.1155/2019/3548284
|
3 |
Gang Li, Rafael S. Rios, Xin-Xin Wang, Yue Yu, Kenneth I. Zheng, Ou-Yang Huang, Liang-Jie Tang, Hong-Lei Ma, Yi Jin, Giovanni Targher, Christopher D. Byrne, Xiao-Yan Pan, Ming-Hua Zheng. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease. British Journal of Nutrition 2022; 127(11): 1613 doi: 10.1017/S0007114521002415
|
4 |
Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2023; 42(6): 987 doi: 10.1016/j.clnu.2023.03.021
|
5 |
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2022; 41(10): 2364 doi: 10.1016/j.clnu.2022.07.003
|
6 |
Yu Zhai, Qian Xiao. The Common Mechanisms of Sarcopenia and NAFLD. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/6297651
|
7 |
G Henin, N Lanthier, G Dahlqvist. Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target?. Acta Gastro Enterologica Belgica 2022; 85(4): 611 doi: 10.51821/85.4.10899
|
8 |
Beom-Jun Kim, Seong Hee Ahn, Seung Hun Lee, Seongbin Hong, Mark W. Hamrick, Carlos M. Isales, Jung-Min Koh. Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study. Aging 2019; 11(13): 4547 doi: 10.18632/aging.102068
|
9 |
Alessio Molfino, Sheeva Johnson, Valentina Medici. The Challenges of Nutritional Assessment in Cirrhosis. Current Nutrition Reports 2017; 6(3): 274 doi: 10.1007/s13668-017-0216-8
|
10 |
Eun Kyung Choe, Hae Yeon Kang, Boram Park, Jong In Yang, Joo Sung Kim. The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass. Journal of Clinical Medicine 2018; 7(10): 310 doi: 10.3390/jcm7100310
|
11 |
Roger F. Butterworth. L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/8182195
|
12 |
Yun Kyung Cho, Han Na Jung, Eun Hee Kim, Min Jung Lee, Joong‐Yeol Park, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung. Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography. Obesity 2023; 31(6): 1547 doi: 10.1002/oby.23733
|
13 |
Luigi Schiavo, Luca Busetto, Manuela Cesaretti, Shira Zelber-Sagi, Liat Deutsch, Antonio Iannelli. Nutritional issues in patients with obesity and cirrhosis. World Journal of Gastroenterology 2018; 24(30): 3330-3346 doi: 10.3748/wjg.v24.i30.3330
|
14 |
Joana RIGOR, Raquel VASCONCELOS, Rogério LOPES, Teresa MOREIRA, Pedro BARATA, Daniela MARTINS-MENDES. Associations between muscle mass, strength, and performance and non-alcoholic fatty liver disease. Minerva Gastroenterology 2023; 69(3) doi: 10.23736/S2724-5985.22.03097-2
|
15 |
Ji Yeon Ryu, Hyung Muk Choi, Hyung-In Yang, Kyoung Soo Kim. Dysregulated Autophagy Mediates Sarcopenic Obesity and Its Complications via AMPK and PGC1α Signaling Pathways: Potential Involvement of Gut Dysbiosis as a Pathological Link. International Journal of Molecular Sciences 2020; 21(18): 6887 doi: 10.3390/ijms21186887
|
16 |
Joise Teixeira, Cláudio Augusto Marroni, Paula Rosales Zubiaurre, Ana Henz, Lais Faina, Lilian Kethelyn Pinheiro, Claudio Cora Mottin, Sabrina Alves Fernandes. Phase angle and non-alcoholic fatty liver disease before and after bariatric surgery. World Journal of Hepatology 2020; 12(11): 1004-1019 doi: 10.4254/wjh.v12.i11.1004
|
17 |
B.S. van der Meij, Vera C. Mazurak. Fish oil supplementation and maintaining muscle mass in chronic disease: state of the evidence. Current Opinion in Clinical Nutrition & Metabolic Care 2020; 23(3): 164 doi: 10.1097/MCO.0000000000000648
|
18 |
So-hyeon Hong, Kyung Mook Choi. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. International Journal of Molecular Sciences 2020; 21(2): 494 doi: 10.3390/ijms21020494
|
19 |
Diana R. Mager, Krista MacDonald, Reena L. Duke, Hayford M. Avedzi, Edward C. Deehan, Jason Yap, Kerry Siminoski, Andrea M. Haqq. Comparison of Body Composition, Muscle Strength and Cardiometabolic Profile in Children with Prader-Willi Syndrome and Non-Alcoholic Fatty Liver Disease: A Pilot Study. International Journal of Molecular Sciences 2022; 23(23): 15115 doi: 10.3390/ijms232315115
|
20 |
Annalisa Cespiati, Marica Meroni, Rosa Lombardi, Giovanna Oberti, Paola Dongiovanni, Anna Ludovica Fracanzani. Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines 2022; 10(1): 182 doi: 10.3390/biomedicines10010182
|
21 |
Muhei Tanaka, Hiroshi Okada, Yoshitaka Hashimoto, Muneaki Kumagai, Hiromi Nishimura, Yohei Oda, Michiaki Fukui. Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography. Liver International 2020; 40(1): 120 doi: 10.1111/liv.14253
|
22 |
Saad Emhmed Ali, Mindie H. Nguyen. Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease—The Union of Two Culprits. Life 2021; 11(2): 119 doi: 10.3390/life11020119
|
23 |
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans‐Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon‐Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterology Journal 2022; 10(7): 663 doi: 10.1002/ueg2.12280
|
24 |
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, Gyorgy Baffy. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications. International Journal of Molecular Sciences 2022; 23(21): 13320 doi: 10.3390/ijms232113320
|
25 |
Mathias Plauth. Comprehensive Guide to Hepatitis Advances. 2023; : 87 doi: 10.1016/B978-0-323-98368-6.00004-5
|
26 |
Andressa OLIVEIRA, Sabrina Alves FERNANDES, Randhall Bruce CARTERI, Cristiane Valle TOVO. EVALUATION OF REST ENERGY EXPENDITURE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE. Arquivos de Gastroenterologia 2021; 58(2): 157 doi: 10.1590/s0004-2803.202100000-27
|
27 |
Tannaz Eslamparast, Aldo J. Montano‐Loza, Maitreyi Raman, Puneeta Tandon. Sarcopenic obesity in cirrhosis—The confluence of 2 prognostic titans. Liver International 2018; 38(10): 1706 doi: 10.1111/liv.13876
|
28 |
Mark L. Dreher. Dietary Patterns and Whole Plant Foods in Aging and Disease. 2018; : 291 doi: 10.1007/978-3-319-59180-3_10
|
29 |
Selena Z. Kuo, Myra Ahmad, Michael A. Dunn, Aldo J. Montano-Loza, Elizabeth J. Carey, Shezhang Lin, Akshata Moghe, Hui-Wei Chen, Maryam Ebadi, Jennifer C. Lai. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation. Transplantation 2019; 103(11): 2312 doi: 10.1097/TP.0000000000002741
|
30 |
Manuela Merli, Barbara Lattanzi, Francesca Aprile. Sarcopenic obesity in fatty liver. Current Opinion in Clinical Nutrition & Metabolic Care 2019; 22(3): 185 doi: 10.1097/MCO.0000000000000558
|
31 |
Hye Jun Lee, Duk Chul Lee, Choon Ok Kim. Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.599339
|